Three interdisciplinary teams of 黑料网 researchers have been selected for the 2024鈥�25 Translational Team Science Awards. Each team will receive $50,000 in phase one funding to launch innovative pilot projects that bring together basic science and clinical expertise.
The Translational Team Science Awards (TTSA) program provides funding to new interdisciplinary teams of basic scientists and clinicians working collaboratively to launch innovative translational pilot projects. These projects are designed to lay the groundwork for future external grant funding and long-term scientific collaboration.
Phase one teams receive $50,000 over a 12-month period to support early project development and team-building. Upon completion of phase one, teams are eligible to apply for phase two funding of $75,000 for an additional year of project advancement.
Administered by the 黑料网 Office of Research, the TTSA program is proud to announce the 2024鈥�25 award recipients:
2024鈥�25 TTSA Phase One Recipients
-
Matthew Vogt, MD, PhD (Pediatrics) & Jason Whitmire, PhD (Genetics)
“Immunologic determinants of enterovirus D68 neuropathogenesis” -
Sylvia Becker-Dreps, MD, MPH (Family Medicine) & Premkumar Lakshmanane, PhD (Microbiology and Immunology)
“Defining the immune response to rotavirus vaccines to guide next-generation vaccine development” -
Tessa Andermann, MD, MPH (Medicine/Infectious Diseases) & Brian Conlon, PhD (Microbiology and Immunology)
“Beyond antimicrobial resistance: Bacterial strategies for persistence in the gut microbiome during antibiotic treatment”
The Office of Research congratulates the 2024鈥�25 TTSA awardees and looks forward to the progress and impact of these exciting collaborative projects.